A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new ...
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and ...
Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...
Add Yahoo as a preferred source to see more of our stories on Google. While the U.S. National Institutes of Health says that around 500,000 Americans are currently diagnosed with Parkinson’s disease, ...
Insomnia is associated with an increased risk for Parkinson’s disease (PD) in a new long-term study, suggesting it’s more ...
Motor function improved with a favorable safety profile for patients with Parkinson’s disease who used tavapadon while receiving oral levodopa, according to a study published in JAMA Neurology.This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results